CMS Finalizes New Value-Based Payment Model for Cardiology & Pain Management
Medicare to Test New Payment Model Aimed at Improving Heart Failure and Back Pain Care
Starting in 2027, Medicare will roll out a new payment model designed to incentivize better care and lower costs for patients with heart failure and chronic low back pain. The Ambulatory Specialty Model (ASM), finalized by the Centers for Medicare & Medicaid Services (CMS), represents a significant shift towards value-based care in specialized medicine, potentially impacting nearly a quarter of all U.S. physicians in the affected specialties.
The move comes as healthcare costs continue to rise, and as policymakers seek ways to reward quality and efficiency rather than simply the volume of services provided. According to the Centers for Disease Control and Prevention, heart disease remains the leading cause of death in the United States, while chronic pain conditions, including back pain, contribute significantly to disability and lost productivity.
A Two-Sided Risk Approach
Unlike previous Medicare payment initiatives, the ASM introduces a “two-sided risk” component. This means physicians won’t just be rewarded for good performance; they could also see their Medicare payments reduced if they don’t meet certain quality and cost benchmarks. The model will evaluate specialists based on four key areas: quality of care, cost efficiency, improvement activities, and interoperability – how well their electronic health records communicate with other systems.
“This isn’t just about penalizing doctors for poor outcomes,” explains Dr. Livia Grant, Senior Health Editor at worldys.news. “It’s about creating a system where physicians are actively encouraged to collaborate, adopt evidence-based practices, and focus on the overall well-being of their patients. The emphasis on regional peer comparison is also crucial – it acknowledges that healthcare delivery varies geographically and sets realistic expectations.” For more on value-based care and its impact on patients, see our comprehensive guide to value-based care.
How the Model Will Work
The ASM will be implemented in select geographic areas, encompassing roughly one-quarter of Core-Based Statistical Areas (CBSAs) across the country. Clinicians participating in the model will be assessed on their performance in treating patients with either heart failure or chronic low back pain. CMS will use existing episode-based cost measures (EBCMs) to evaluate cost efficiency, and will focus on quality measures related to appropriate utilization, evidence-based care, and patient-reported outcomes.
A key difference from the existing Merit-based Incentive Payment System (MIPS) is that the ASM will benchmark performance against peers treating the same condition. Under MIPS, a cardiologist’s performance is compared to that of all MIPS-eligible clinicians, regardless of specialty. The ASM aims for a more focused and relevant comparison.
Impact on Practices and Patients
The ASM is expected to have a significant impact on specialty practices, particularly those already involved in Accountable Care Organizations (ACOs). Practices will need to invest in data analytics, care coordination, and technology to effectively participate in the model. This may include redesigning workflows to prioritize longitudinal patient management and adopting tools to capture functional outcomes.
For patients, the ASM could lead to more coordinated and effective care. The emphasis on patient-reported outcomes and experience is intended to ensure that care is aligned with individual needs and preferences. However, some experts caution that the model could also create unintended consequences, such as increased administrative burden for physicians or a reluctance to treat complex patients.
A Global Perspective on Value-Based Care
The United States isn’t alone in its pursuit of value-based care. Countries like the United Kingdom’s National Health Service (NHS) and healthcare systems in Germany and Australia are also experimenting with similar models. The World Health Organization advocates for universal health coverage, which often includes a focus on improving the value of healthcare services. The ASM represents a step towards that goal in the U.S., but its success will depend on careful implementation and ongoing evaluation.
The ASM will be tested over five performance years, from 2027 to 2033, with payment adjustments applied on a two-year lag. In the initial year (2029), adjustments could range from -9% to +9%, with the potential for larger adjustments in subsequent years. Clinicians must have historically treated at least 20 applicable episodes per year to participate.
Healthcare organizations and specialty practices should begin preparing now by assessing their eligibility, conducting readiness evaluations, and reviewing their electronic health record capabilities. Financial modeling is also essential to anticipate potential financial exposure under the two-sided risk framework.